Stockreport

Galena Q1 net loss $11.7M; two legal issues resolved; shares off 6% after hours [Seeking Alpha]

GALENA BIOPHARMA  (GALE) 
PDF Galena Biopharma's (NASDAQ: GALE ) net loss for Q1 narrowed to ($11.7M) from ($16.5M) while its unrestricted cash balance improved 52% to $27.6M. CEO Stephen [Read more]